Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 23

1.

Ustekinumab use in patients with severe psoriasis co-infected with hepatitis B and/or C.

Siegel SAR, Winthrop KL, Ehst BD, Ortega Loayza A.

Br J Dermatol. 2019 May;180(5):1232-1233. doi: 10.1111/bjd.17444. Epub 2019 Jan 16. No abstract available.

PMID:
30460766
2.

Nicolau syndrome and localized panniculitis: a report of dual diagnoses with an emphasis on morphea profunda-like changes following injection with glatiramer acetate.

Mott SE, Peña ZG, Spain RI, White KP, Ehst BD.

J Cutan Pathol. 2016 Nov;43(11):1056-1061. doi: 10.1111/cup.12791. Epub 2016 Sep 8.

PMID:
27516414
3.

Demographics, clinical disease characteristics, and quality of life in a large cohort of psoriasis patients with and without psoriatic arthritis.

Truong B, Rich-Garg N, Ehst BD, Deodhar AA, Ku JH, Vakil-Gilani K, Danve A, Blauvelt A.

Clin Cosmet Investig Dermatol. 2015 Nov 4;8:563-9. doi: 10.2147/CCID.S90270. eCollection 2015.

4.

Unique Cutaneous Reaction to Second- and Third-Generation Tyrosine Kinase Inhibitors for Chronic Myeloid Leukemia.

Patel AB, Solomon AR, Mauro MJ, Ehst BD.

Dermatology. 2016;232(1):122-5. doi: 10.1159/000437383. Epub 2015 Sep 10.

PMID:
26352467
5.

Triple antibiotic combination therapy may improve but not resolve granuloma annulare.

Simpson B, Foster S, Ku JH, Simpson EL, Ehst BD.

Dermatol Ther. 2014 Nov-Dec;27(6):343-7. doi: 10.1111/dth.12159. Epub 2014 Jul 22.

PMID:
25053171
6.

A novel, short, and simple screening questionnaire can suggest presence of psoriatic arthritis in psoriasis patients in a dermatology clinic.

Garg N, Truong B, Ku JH, Devere TS, Ehst BD, Blauvelt A, Deodhar AA.

Clin Rheumatol. 2015 Oct;34(10):1745-51. doi: 10.1007/s10067-014-2658-3. Epub 2014 May 15.

PMID:
24827874
7.

Persistence of Staphylococcus aureus colonization among individuals with immune-mediated inflammatory diseases treated with TNF-α inhibitor therapy.

Varley CD, Deodhar AA, Ehst BD, Bakke A, Blauvelt A, Vega R, Yamashita S, Winthrop KL.

Rheumatology (Oxford). 2014 Feb;53(2):332-7. doi: 10.1093/rheumatology/ket351. Epub 2013 Oct 29.

PMID:
24173434
8.

Pityriasis rubra pilaris-like eruption associated with the multikinase inhibitor ponatinib.

Jack A, Mauro MJ, Ehst BD.

J Am Acad Dermatol. 2013 Nov;69(5):e249-e250. doi: 10.1016/j.jaad.2013.04.061. No abstract available.

PMID:
24124847
9.

Implications for biologic therapy: Staphylococcus aureus decolonization of individuals with a history of recurrent skin and soft-tissue infections.

Ku JH, Winthrop KL, Varley CD, Sullivan A, Ehst BD, Blauvelt A, Deodhar AA.

JAMA Dermatol. 2013 Aug;149(8):986-9. doi: 10.1001/jamadermatol.2013.4405. No abstract available.

PMID:
23784002
11.

Chronic ulcerative herpes simplex virus infection of the vulva.

Griffith-Bauer K, O'Hearn M, Ehst BD.

Case Rep Dermatol. 2012 Sep;4(3):192-6. doi: 10.1159/000342953. Epub 2012 Sep 12.

12.

Cutaneous manifestations of internal malignancy.

Ehst BD, Minzer-Conzetti K, Swerdlin A, Devere TS.

Curr Probl Surg. 2010 May;47(5):384-445. doi: 10.1067/j.cpsurg.2010.01.003. Review. No abstract available.

PMID:
20363406
13.

Toll-like receptor 2, 4, 7 and 9 expression in primary cutaneous CD30+ T-cell lymphoma.

Knol AC, Ehst BD, Dompmartin A, Quéreux G, Nguyen JM, Comoz F, Renaut JJ, Khammari A, Vonderheid EC, Dréno B.

Br J Dermatol. 2009 Dec;161(6):1414-6. doi: 10.1111/j.1365-2133.2009.09470.x. Epub 2009 Sep 28. No abstract available.

PMID:
19785598
14.

Nephrogenic systemic fibrosis: incidence, associations, and effect of risk factor assessment--report of 33 cases.

Perez-Rodriguez J, Lai S, Ehst BD, Fine DM, Bluemke DA.

Radiology. 2009 Feb;250(2):371-7. doi: 10.1148/radiol.2502080498.

15.

Primary cutaneous CD30+ anaplastic large cell lymphoma responds to imiquimod cream.

Ehst BD, Dréno B, Vonderheid EC.

Eur J Dermatol. 2008 Jul-Aug;18(4):467-8. doi: 10.1684/ejd.2008.0450. Epub 2008 Jun 23. No abstract available.

PMID:
18573730
16.

Adalimumab therapy for recalcitrant pyoderma gangrenosum.

Fonder MA, Cummins DL, Ehst BD, Anhalt GJ, Meyerle JH.

J Burns Wounds. 2006 Nov 20;5:e8.

17.

CD4+ T-cell help controls CD8+ T-cell memory via TRAIL-mediated activation-induced cell death.

Janssen EM, Droin NM, Lemmens EE, Pinkoski MJ, Bensinger SJ, Ehst BD, Griffith TS, Green DR, Schoenberger SP.

Nature. 2005 Mar 3;434(7029):88-93.

PMID:
15744305
18.

Alcohol-induced application site erythema after topical immunomodulator use and its inhibition by aspirin.

Ehst BD, Warshaw EM.

Arch Dermatol. 2004 Aug;140(8):1014-5. No abstract available.

PMID:
15313828
20.
21.

Distinct dendritic cell populations sequentially present antigen to CD4 T cells and stimulate different aspects of cell-mediated immunity.

Itano AA, McSorley SJ, Reinhardt RL, Ehst BD, Ingulli E, Rudensky AY, Jenkins MK.

Immunity. 2003 Jul;19(1):47-57.

22.

Bacterial flagellin is an effective adjuvant for CD4+ T cells in vivo.

McSorley SJ, Ehst BD, Yu Y, Gewirtz AT.

J Immunol. 2002 Oct 1;169(7):3914-9.

23.

CD28/B7 interactions deliver a unique signal to naive T cells that regulates cell survival but not early proliferation.

Sperling AI, Auger JA, Ehst BD, Rulifson IC, Thompson CB, Bluestone JA.

J Immunol. 1996 Nov 1;157(9):3909-17.

PMID:
8892622

Supplemental Content

Support Center